Profile

ANDREAS LARENTZAKIS

GENERAL SURGEON

EXTERNAL ASSOCIATE, PERITONEAL SURGICAL ONCOLOGY
  1. General
  • Education & Academic Titles

    MD, Medicine, National & Kapodistrian University of Athens, Greece
    PhD, Medicine, Surgery, National & Kapodistrian University of Athens, Greece
    MSc, Medicine, HPB Surgery, Democritus University of Thrace, Greece
    Residency, General Surgery, 1st Propaedeutic Surgical Clinic, Athens Medical School, Hippocrateion Athens General Hospital, Greece, and Department of Surgery (Chirurgische Klinik und Poliklinik), “Klinikum rechts der Isar” of the
    Technical University of Munich, Munich, Germany

    • Harvard Medical School Fellow in Surgery
    • Peritoneal Surgical Oncology Fellow, European Society of Surgical Oncology (ESSO), European School of Peritoneal
    • Surface Oncology (ESPSO) Certified
    • Fellow of American College of Surgeons
    • Scientific Collaborator of Surgical Oncology MSc Program, National & Kapodistrian University of Athens, Greece
    • Academic Scholar, National & Kapodistrian University of Athens, 1st Propaedeutic Surgical Clinic, Greece
  • Doctoral Thesis
    Experimental study of tissue oxygenation with microdialysis in hemorrhagic shock resuscitation, Surgery, Athens Medical School, National & Kapodistrian University of Athens, Greece
  • Professional Experience
    • Medical licence, Greece
    • Surgical Board Certification, Greece
    • General Medical Council (GMC), UK
    • Harvard Medical School Research Fellow in Surgery, Boston, USA
    • Post-DOC, Massachusetts General Hospital, Boston, USA
    • Senior Clinical Fellow in General Surgery, Autologus Gastrointestinal Reconstruction (AuGIR), Intestinal Failure Unit
    • at Salford Royal NHS Foundation Trust, University Teaching Hospital, Manchester, UK
    • Peritoneal Surgical Oncology Clinical Fellow, Peritoneal Tumour Service , Colorectal and Peritoneal Oncology Centre, Christie Hospital NHS Foundation Trust, Manchester, UK
    • Attending Surgeon, 6th Surgical Clinic, IASO General, Holargos, Greece
    • Clinical Lead, Consultant Surgeon, Peritoneal Surface Malignancies & Cytoreductive Surgery/HIPEC Unit (Accredited Unit / Β’ 797 / 12/03/2020)
    • Academic Scholar, National & Kapodistrian University of Athens, 1st Propaedeutic Surgical Clinic, Greece
  • Clinical Interest
    • Surgical Oncology – Cytoreductive.Surgery – HIPEC: Peritoneal Surface Malignancies – Pseudomyxoma Peritonei – Tumours of the Appendix, Small, and Large Bowel
    • Laparoscopic Surgery – Minimally Invasive Surgery
    • Hernias of the abdominal wall
    • Gallbladder and biliary tree diseases
    • Innovation in Medicine – Artificial Intelligence
  • Awards & Distinctions
    • Award, Hellenic Surgical Society, 2012
    • Scholarship, Hellenic Surgical Society, 2012
    • Scholarship, ELPEN, S.a. Research Center, 2012
    • Scholarship, ELPEN, S.a. Research Center, 2013
    • Included in HARVARD CATALYST του Harvard University, 2013
    • 1st Price Award, Βραβείο Harvard Medical School Department of Surgery, 3rd Annual HMS Surgery Research Day, 2014
    • Cover Figure World Journal of Gastroenterology, 2018.
    • Awarded in recognition for the e-Poster presentation: American College of Surgeons, ACS Clinical Congress, 2018.
  • Recent Publications
    • Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. COVIDSurg Collaborative. Lancet Oncol. 2021 Nov;22(11):1507-1517.
    • SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. COVIDSurg Collaborative, GlobalSurg Collaborative. Anaesthesia. 2021 Aug 24. doi: 10.1111/anae.15563.
    • 30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries. GENEVA Collaborative. Obes Surg. 2021 Oct;31(10):4272-4288. doi: 10.1007/s11695-021-05493-9.
    • Artificial intelligence (AI) in medicine as a strategic valuable tool. Larentzakis A, Lygeros N. PAMJ. 2021 Feb 17;38:184. doi: 10.11604/pamj.2021.38.184.28197.
    • SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. COVIDSurg Collaborative, GlobalSurg Collaborative. Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101.
    • Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. COVIDSurg Collaborative. J Clin Oncol. 2021 Jan 1;39(1):66-78.
    • Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM). Larentzakis A, et al. Eur J Surg Oncol. 2019 Dec;45(12):2310-2315. doi: 10.1016/j.ejso.2019.07.008.
    • Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury. Mesar T, Larentzakis A, et al. JAMA Surg. 2017 Jun 1;152(6):574-580.
  • Membership in Societies and Editorial Boards
    • Hellenic Surgical Society
    • Hellenic Society of Surgical Oncology
    • Hellenic Society of Endoscopic Surgery
    • Harvard Medical School Postgraduate Association
    • European Association for Endoscopic Surgery
    • European Society of Surgical Oncology
    • Fellow of American College of Surgeons

    Editorial Board Member in 14 International Medical Journals
    Reviewer in 37 International Medical Journals, some among Nature, Cell, and Lancet groups.

  • Research

    Principal Investigator or Co-Investigator or Study Member or Study Coordinator in:

    • 3 laboratories in Greece and USA
    • 42 clinical research projects in Greece, UK, and USA
    • 5 international multicentre clinical studies
    • 8 experimental research projects in Greece and USA